“A Repurposed Duo: Empagliflozin-Metformin Triggers a Metabolic Crisis in Cervical Cancer by Disrupting the Acyl-CoA CoA Ratio via Dual Inhibition of PPAT and CPT1A”. Journal of Cancer Research Updates, vol. 14, Dec. 2025, pp. 247-65, https://doi.org/10.30683/1929-2279.2025.14.26.